Found 6 matching trials
Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome PHASE2 Primary liver cancer is a malignant tumor with a very poor prognosis. Hepat...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure NA This study is a prospective, randomized controlled, multicenter clinical st...
Show More Location
Multiple Locations
Learn More & Join Trial
TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens PHASE2 Liver metastasis is the main reason that affects the survival rates of pati...
Show More Location
the first affiliated hospital, Sun-Yat sen university
Learn More & Join Trial
cTACE or DEB-TACE+HAIC Combined With Regorafenib ยฑ Anti-PD1 Antibody for uHCC N/A explore the effectiveness and safety of conventional transarterial chemoemb...
Show More Location
Multiple Locations
Learn More & Join Trial
The Application of Locoregional Therapy Combined With Systemic Therapy in the Perioperative Period of Huge Hepatocellular Carcinoma: A Retrospective Cohort Study N/A This retrospective cohort study collected data of patients with huge hepato...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
HAIC Combined With Camrelizumab and TKI for Unresectable Hepatocellular Carcinoma After TACE Failure PHASE2 The efficacy and safety of HAIC combined with tyrosine kinase inhibitor and...
Show More Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial